|Articles|March 31, 2021
COPD Spotlight
Author(s)Gianna Melillo
Advertisement
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Bronchiectasis Hospitalizations Deadlier, Costlier Than Those for COPD, Asthma
2
FDA Approves Sevabertinib for Nonsquamous NSCLC
3
Family Caregivers Report Weak Coordination With Medical Professionals
4
FDA Approves Selumetinib for Adults With Neurofibromatosis Type 1
5










































